Skip to main content
. Author manuscript; available in PMC: 2017 Mar 6.
Published in final edited form as: Mucosal Immunol. 2016 Aug 24;10(2):555–564. doi: 10.1038/mi.2016.70

Figure 4.

Figure 4

S1PR1 blockade reduces KLRG1− CD4 T cells in the lung vasculature.\r\n (A) Representative FACS plots of Lung I-Ab:ESAT-64-17 tetramer+ CD4 T cells from H56/CAF01-vaccinated (lower plots) and adjuvant control (upper plots) C57BL/6 mice infected for 7 weeks with Mtb followed by 48hr treatment with (right) or without (left) FTY720. (B) Bar graph shows the proportion of KLRG1− of I-Ab:ESAT-64-17 tetramer+ CD4 T cells in the lung vasculature (IV+) for each treatment group. Bar, mean+/−SEM of n=3 mice per group. *p<0.05.\r\n